Immunodeficiency-associated pneumonia in adults  

作　　者：Yulin Zhang Yingmin Ma 

机构地区：[1]Department of Respiratory Infectious Diseases,Beijing Youan Hospital,Capital Medical University,Beijing,China

出　　处：《感染控制(英文)》2024年第3期59-68,共10页

基　　金：National Natural Science Foundation of China(81873761,81571178,81371399);National 13th Five-Year Plan Major Science and Technology Project(2018ZX10302104).

摘　　要：The spread of AIDS and increasing use of immunosuppressive therapy have led to a yearly increase in the incidence of immunodeficiency-associated pneumonia(IAP).The pathogenic spectrum,clinical features,and prognosis of IAP differ significantly from those of pneumonia in populations without immunodeficiency.Traditional classifications and guidelines for pneumonia,such as community-acquired,hospital-acquired,and ventilator-associated pneumonia,offer limited guidance for the clinical management of IAP,especially in newly diagnosed individuals who are unaware of their immunodeficient status.On the basis of these considerations,this article provides a detailed overview of the general concepts and types of immunodeficiency,pathogen spectrum of IAP,and clinical characteristics and treatment principles of common IAPs,providing a reference for clinical practice.

关 键 词：IMMUNODEFICIENCY PNEUMONIA PATHOGENS DIAGNOSIS TREATMENT 

分 类 号：R73[医药卫生—肿瘤]